Pemphigus vulgaris is a rare autoimmune disease that causes painful blistering on mucous membranes like the mouth, eyes, or genitals. It can cause serious complications if it isn’t treated. If you ...

Understanding the Context

The New England Journal of Medicine: Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequately compared in clinical trials. In a randomized, controlled trial, we assigned patients with ... The New England Journal of Medicine: Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin Pemphigus vulgaris is a potentially fatal autoimmune mucocutaneous blistering disease. Conventional therapy consists of high-dose corticosteroids, immunosuppressive agents, and intravenous immune ...

Key Insights